Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis

被引:0
作者
Schroeder, Sophie [1 ]
Epple, Robert [1 ]
Fischer, Andre [1 ,2 ,3 ]
Schettler, Volker J. J. [4 ,5 ]
机构
[1] German Ctr Neurodegenerat Dis DZNE Gottingen, Dept Epigenet & Syst Med Neurodegenerat Dis, Gottingen, Germany
[2] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany
[3] Univ Gottingen, Cluster Excellence Multiscale Bioimaging Mol Machi, Gottingen, Germany
[4] Ctr Nephrol Gottingen GbR, Gottingen, Germany
[5] Nephrol Zentrum Gottingen GbR, An der Lutter 24, D-37075 Gottingen, Germany
关键词
coronary heart disease; exosomes; hemodialysis; lipoprotein apheresis; risk reduction; EXTRACELLULAR VESICLES; ATHEROSCLEROSIS; MICROPARTICLES; RISK;
D O I
10.1111/1744-9987.14172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionExtracellular vesicles (EVs) have been identified as playing a role in atherosclerosis.MethodsA group of 37 hypercholesterolemic patients with atherosclerotic cardiovascular diseases (ASCVD) and 9 patients requiring hemodialysis (HD) were selected for the study.ResultsEVs were comparably reduced by various LA methods (Thermo: 87.66% +/- 3.64, DALI: 87.96% +/- 4.81, H.E.L.P.: 83.38% +/- 11.98; represented as SEM). However, LDL-C (66%; 55%; 75%) and Lp(a) (72%; 67%; 79%) were less effectively reduced by DALI. There was no significant difference in the reduction of EVs when comparing different techniques, such as hemoperfusion (DALI; n = 13), a precipitation (H.E.L.P.; n = 5), and a double filtration procedure (Thermofiltration; n = 19). Additionally, no effect of hemodialysis on EVs reduction was found.ConclusionsThe study suggests that EVs can be effectively removed by various LA procedures, and this effect appears to be independent of the specific LA procedure used, as compared to hemodialysis.
引用
收藏
页码:863 / 870
页数:8
相关论文
共 34 条
  • [1] Bergmark BA, 2022, LANCET, V399, P1347, DOI 10.1016/S0140-6736(21)02391-6
  • [2] Extracellular vesicles in coronary artery disease
    Boulanger, Chantal M.
    Loyer, Xavier
    Rautou, Pierre-Emmanuel
    Amabile, Nicolas
    [J]. NATURE REVIEWS CARDIOLOGY, 2017, 14 (05) : 259 - 272
  • [3] Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia
    Connolly, Katherine D.
    Willis, Gareth R.
    Datta, Dev B. N.
    Ellins, Elizabeth A.
    Ladell, Kristin
    Price, David A.
    Guschina, Irina A.
    Rees, D. Aled
    James, Philip E.
    [J]. JOURNAL OF LIPID RESEARCH, 2014, 55 (10) : 2064 - 2072
  • [4] Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia
    Dlouha, Dana
    Blaha, Milan
    Huckova, Pavlina
    Lanska, Vera
    Hubacek, Jaroslav Alois
    Blaha, Vladimir
    [J]. GENES, 2023, 14 (08)
  • [5] Analysis of circulating miRNAs in patients with familial hypercholesterolaemia treated by LDL/Lp(a) apheresis
    Dlouha, Dana
    Blaha, Milan
    Blaha, Vladimir
    Fatorova, Ilona
    Hubacek, Jaroslav A.
    Stavek, Petr
    Lanska, Vera
    Parikova, Alena
    Pitha, Jan
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2017, 30 : 128 - 134
  • [6] Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
    Engelen, Suzanne E.
    Robinson, Alice J. B.
    Zurke, Yasemin-Xiomara
    Monaco, Claudia
    [J]. NATURE REVIEWS CARDIOLOGY, 2022, 19 (08) : 522 - 542
  • [7] Lipoprotein(a) association with residual risk: what has inflammation got to do with it?
    Farukhi, Zareen M.
    Mora, Samia
    [J]. EUROPEAN HEART JOURNAL, 2024, 45 (12) : 1055 - 1057
  • [8] Extracellular vesicles in atherothrombosis and cardiovascular disease: Friends and foes
    Giro, Oriol
    Jimenez, Amanda
    Pane, Adriana
    Badimon, Lina
    Ortega, Emilio
    Chiva-Blanch, Gemma
    [J]. ATHEROSCLEROSIS, 2021, 330 : 61 - 75
  • [9] Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?
    Heigl, Franz
    Pflederer, Tobias
    Klingel, Reinhard
    Hettich, Reinhard
    Lotz, Norbert
    Reeg, Harduin
    Schettler, Volker J. J.
    Roeseler, Eberhard
    Gruetzmacher, Peter
    Hohenstein, Bernd
    Julius, Ulrich
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2019, 40 : 23 - 29
  • [10] Novel methodologies for biomarker discovery in atherosclerosis
    Hoefer, Imo E.
    Steffens, Sabine
    Ala-Korpela, Mika
    Baeck, Magnus
    Badimon, Lina
    Bochaton-Piallat, Marie-Luce
    Boulanger, Chantal M.
    Caligiuri, Giuseppina
    Dimmeler, Stefanie
    Egido, Jesus
    Evans, Paul C.
    Guzik, Tomasz
    Kwak, Brenda R.
    Landmesser, Ulf
    Mayr, Manuel
    Monaco, Claudia
    Pasterkamp, Gerard
    Tunon, Jose
    Weber, Christian
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (39) : 2635 - +